Chris Mattingly

Chris Mattingly is an experienced pharmaceutical sales professional with a diverse background in specialty account management and sales. Currently serving as a Specialty Account Manager at Axsome Therapeutics, Inc. since May 2022, Chris markets SUNOSI, a medication for excessive daytime sleepiness. Prior experience includes roles as a Specialty Sales Consultant at Jazz Pharmaceuticals, where Chris also promoted SUNOSI, and as a Clinical Sales Specialist at Medexus Pharma USA, marketing Rasuvo for rheumatic conditions. Chris's career began at Allergan, where significant contributions included the successful launch of multiple psychiatric and neurological medications. Additional experience includes a role as Oncology/Infectious Disease Specialty Sales Professional at Insys Therapeutics and an Area Manager position at Enterprise. Chris holds a Bachelor of Business Administration in Finance from the University of Kentucky.